Nutri Pharmaceuticals Research Stock

Nutri Pharmaceuticals Research, Inc. engages in the development and marketing of powdered nutritional ingredients. The company provides a range of powdered oils for functional food; food supplement; pharmaceutical; cosmetic; pet food and animal feed applications.

The company has a patent-pending O2P Powderization process. This patent-pending process converts edible oils, gels or pastes into a powder. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues.

The company offers approximately 50 shelf-stable powders. It also applies O2P technology to a third-party's oil, paste or gel through an arrangement called tolling. It has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok.

Collaborations

The company has collaboration with Baylor University's Institute of Metabolic Disease University for the development of a medium-odd chain fatty acid formulation for the reduction of muscle weakness and degeneration.